In addition, chronic cardiotrophin-1 treatment reduced body weight, improved insulin resistance5, and resolved hepatic steatosis6 in ob/ob and high-fed-diet obese mice, suggesting that cardiotrophin-1 is a promising therapy for obesity, diabetes, and non-alcoholic fatty liver disease. The gene discussed is CTF1; the disease is metabolic dysfunction-associated steatotic liver disease.